Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYBiomedicines

Prior Ustekinumab Exposure and Ulcerative Colitis Are Associated with Suboptimal Trough Levels in Patients Receiving Advanced-Line Vedolizumab or Ustekinumab for Inflammatory Bowel Disease: A Cross-Sectional Cohort Study

4 affiliations
  1. 1Paediatric Centre, , 1083 Budapest, Hungary; (P.N.); (A.D.-G.); (N.J.B.); (A.B.); (B.P.); (L.T.); (A.J.S.)
  2. 2Department of Laboratory Medicine, , 1089 Budapest, Hungary; (K.K.); (B.V.)
  3. 3Department of Surgery, Transplantation and Gastroenterology, , 1082 Budapest, Hungary;
  4. 4Department of Internal Medicine and Oncology, , 1083 Budapest, Hungary;

Related

  1. Exploratory baseline mucosal transcriptomics and vedolizumab response in ulcerative colitis
    Liang Zhang, Jian Liu, Chenfei Liang +3
    PLOS OnePeer-reviewedCC BYFull textGenetics & genomicsImmunologyPLOSEurope PMC
  2. Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden
    Oana Maria Catana, Ramona Cioboata, Denisa Maria Mitroi +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Mapping mitochondria-associated research in inflammatory bowel disease : A bibliometric and network analysis
    Houshu Tu, Menglin Chen, Panpan Zhu +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
    Diyaer Abuduaini, Diernu Simayi, Mihelayi Maimaiti +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Nicotinamide Mononucleotide Is Associated with Attenuation of OGD/R-Induced Pro-Inflammatory Programs in Microglia: Transcriptomic Evidence Converging on the NLRP3 Inflammasome and Lipid-Droplet-Related Molecular Signatures
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{nagypal2026prior,
  title = {{Prior Ustekinumab Exposure and Ulcerative Colitis Are Associated with Suboptimal Trough Levels in Patients Receiving Advanced-Line Vedolizumab or Ustekinumab for Inflammatory Bowel Disease: A Cross-Sectional Cohort Study}},
  author = {Petra Nagypál and Krisztián Kovács and Barna Vásárhelyi and Antal Dezsőfi-Gottl and Pál Miheller and Ákos Iliás and Nóra Judit Béres and Anna Balogh and Bence Prehoda and Luca Tóbi and Attila József Szabó and Áron Cseh},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13702429},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prior Ustekinumab Exposure and Ulcerative Colitis Are Associated with Suboptimal Trough Levels in Patients Receiving Advanced-Line Vedolizumab or Ustekinumab for Inflammatory Bowel Disease: A Cross-Sectional Cohort Study
AU  - Petra Nagypál
AU  - Krisztián Kovács
AU  - Barna Vásárhelyi
AU  - Antal Dezsőfi-Gottl
AU  - Pál Miheller
AU  - Ákos Iliás
AU  - Nóra Judit Béres
AU  - Anna Balogh
AU  - Bence Prehoda
AU  - Luca Tóbi
AU  - Attila József Szabó
AU  - Áron Cseh
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13702429
SN  - 2227-9059
ER  -